Patent & IP news for September 23, 2015

Not So Fast – “Happy Birthday To You” May Not Be in the Public Domain from blawgit.com

The World’s Most popular Song You all know the tune, so why do you rarely hear the song Happy Birthday To You in movies and on television? The reason is that from 1988 until ...

Share via E–mail | Twitter | Facebook

Expert Institute’s Best Legal Blog Contest from www.patentbaristas.com

From a field of more than 2,000 potential nominees, Patent Baristas has received enough nominations to join the 250 legal blogs participating in one of the largest competitions for legal blog writing online today ...

Share via E–mail | Twitter | Facebook

The final curtain in the GOLDBEAR saga from ipkitten.blogspot.com

Wrong comparison for this caseHaribo's suit against Lindt's golden chocolate bear has provided the trade mark community a lot to digest (see IPKat posts here, here and here). The premise is interesting ...

Share via E–mail | Twitter | Facebook

Happy Birthday to everyone: candles blown out on infamous royalty claim from ipkitten.blogspot.com

"Happy Birthday to You" is notorious in copyright terms and frequently cited as a reason why copyright needs fundamental reform. The song, allegedly the most widely performed in the world, is over 100 years old ...

Share via E–mail | Twitter | Facebook

Amicus Briefs in Support of Sequenom's Petition for Rehearing En Banc: Paul Gilbert Cole from www.patentdocs.org

By Kevin E. Noonan -- Earlier this summer, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the Federal Circuit affirmed a decision by the District Court for the Northern District of California granting summary judgment of invalidity ...

Share via E–mail | Twitter | Facebook

USPTO Director Addresses ‘Unacceptable’ Gender Gap In Sci/Tech Fields from www.ip-watch.org

The alarming statistic that women hold less than 25 percent of science and technology jobs in the United States, despite making up nearly half of the workforce, brings home the extent to which women are ...

Share via E–mail | Twitter | Facebook

African Group Proposes Permanent Traditional Knowledge Committee At WIPO from www.ip-watch.org

In a couple of weeks, the World Intellectual Property Organization will hold its annual General Assembly. The African Group is asking the Assembly transform the committee devoted to finding a way to protect genetic resources ...

Share via E–mail | Twitter | Facebook

Plaintiff’s Inability to Assert Assignor Estoppel in IPR No Basis for Preliminary Injunction Precluding IPR Petition from docketreport.blogspot.com

The court denied plaintiff's motion for a preliminary injunction precluding defendant from seeking reexamination or inter partes review because plaintiff failed to establish irreparable harm through its inability to raise an assignor estoppel defense ...

Share via E–mail | Twitter | Facebook

Are The UN And WIPO Drifting Apart? from www.ip-watch.org

NEW YORK – As some of the most powerful people on earth prepare to gather here later this week at the United Nations to discuss the biggest problems and opportunities facing humankind for the next 15 ...

Share via E–mail | Twitter | Facebook

High Priced Generic Drugs from patentlyo.com

The news has been abuzz regarding the drug Daraprim and the major price-hike by its US-distributor (Turing Pharma).  According to its website, Turing “acquired” Daraprim in August 2015 from CorePharma who had previously obtained rights ...

Share via E–mail | Twitter | Facebook

Patent owner gets re-hearing at PTAB but still loses in Reexamination 95/001,775 from ipbiz.blogspot.com

In Engineered Plastics v. ADA, the patent owner got a re-hearing but still lost.


The Patent Owner requests reconsideration (hereinafter "Rehearing Request" or "Reh'g Req.") under 37 C.F.R. § 41.79 of our ...

Share via E–mail | Twitter | Facebook

PTAB oddly grants re-hearing in 90/012,087 from ipbiz.blogspot.com


The PTAB decision states the law on re-hearing:


A request for rehearing must state with particularity the points believed to have been misapprehended or overlooked. Arguments not raised in the briefs before the Board and ...

Share via E–mail | Twitter | Facebook

Appellants get no traction at PTAB in Appeal 2013-008852 (Malek) from ipbiz.blogspot.com

From the decision:



We have reviewed the Examiner’s rejections in light of Appellants’ contentions that the Examiner has erred. Further, we have reviewed the Examiner’s response to Appellants’ arguments. The Examiner has provided ...

Share via E–mail | Twitter | Facebook

Some facts on Daraprim (Pyrimethamine) from ipbiz.blogspot.com

PEOPLE Magazine introduced a story on Martin Shkreli and the specialty drug Daraprim:


If you guessed, "the kind who would buy a patent for a 62-year-old drug and hike its price 4,000 percent," you ...

Share via E–mail | Twitter | Facebook

Pope Closes Federal Circuit from www.717madisonplace.com

From the Federal Circuit web site: COURT TO CLOSE AT 3:30 PM, ET SEPTEMBER 22, 2015, AND REOPEN SEPTEMBER 24, 2015 Due to the anticipated disruption of access to the Court by its facilities ...

Share via E–mail | Twitter | Facebook

Russian Vladimir Platonov loses degree over plagiarism from ipbiz.blogspot.com

Several German politicians lost graduate degrees over plagiarism; now a Russian suffered the same fate; the Moscow Times reports


The Ministry of Education and Science has stripped a former speaker of the Moscow City Duma ...

Share via E–mail | Twitter | Facebook

Dean Baker's piece on 23 Sept 2015 in the New York Times on pharma patents from ipbiz.blogspot.com

An op-ed by Dean Baker in the New York Times begins:


The United States stands out among wealthy countries in that we give drug companies patent monopolies on drugs that are essential for people’s ...

Share via E–mail | Twitter | Facebook

Thermometer patent wars from ipbiz.blogspot.com



Related to a ruling on MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT, Exergen v. Kaz, 2015 U.S. Dist. LEXIS 117770



As to "intended purpose" vs. substantive claim limitation:


The facts of this case lend themselves ...

Share via E–mail | Twitter | Facebook